Singapore: Harlan Contract Research Services (CRS), a division of Harlan Laboratories, a privately held provider of gene...
Singapore: Accuray, a radiation oncology company, has extended its industry-leading Emerald Service Program for the Tomo...
The fifth edition of the annual BioSpectrum Asia Pacific clinical research organization (CRO) Survey, which is conduct...
Singapore: Shionogi, one of Japan's biggest pharmaceutical companies, has signed a memorandum of understanding (MoU) for...
Big pharma companies are gearing up to combat the shortage of injectables in the US through acquiring companies with app...
Singapore: In an internal probing by the Novartis Pharma, it was revealed that its employees in Japan had failed to repo...
Singapore: AB SCIEX, a global leader in life science analytical technologies, announced a global initiative focused on ...
Singapore: Eisai's US subsidiary Morphotek has opened a new pilot manufacturing plant in Exton, Pennsylvania, for the pr...
Singapore: Japan's largest research organization, Riken has launched two virtual Joint Research Centers with India's pre...
Singapore: Japanese firm, Mitsubishi Electric Corporation, is gearing up to solidify its presence in the bioscience sect...
Singapore: Daiichi Sankyo received approval for a supplemental new drug application (sNDA) for an additional indication ...
Singapore: Daiichi Sankyo and Ranbaxy Laboratories will integrate their business operations in Thailand, in order to lev...
Singapore: The wholly owned subsidiary of Japan-based Takeda Pharmaceutical, Takeda America Holdings, has entered into a...
Singapore: Astellas Pharma and UCB Japan have launched Cimzia (certolizumab pegol) in Japan for adult patients with rheu...
Singapore: US-based MediPurpose, a master distributor and manufacturer of medical products, has announced an addition to...
Singapore: Takeda announced that it will donate $250,000 to Chicago's Museum of Science and Industry mainly to support ...
Singapore: Eisai's US subsidiary entered into a strategic manufacturing alliance with Biogen Idec to bolster the manufa...
Singapore: Dicerna Pharmaceuticals, a RNA interference (RNAi) company focused on developing breakthrough oncology thera...
